Practice
Specialties
Hygiene
Clinical
Business
Cases
Careers
Tariffs
Sign In
Endodontics
Oral & Maxillofacial Surgery
Orofacial Pain
Orthodontics
Pediatrics
Periodontics
Smile Design
Analgesics: Page 30
Anesthesia training model aids dental students
By
Rosemary Frei, MSc
Can a sophisticated plastic model of the teeth, gums, and oral cavity help dental students learn to give local anesthesia injections with less pain and greater success? A study by Dutch dentistry professors suggests it can.
August 18, 2010
U.S. sedation, anesthesia practices vary widely
By
DrBicuspid.com staff writers
Significant variation exists in the training for and practice of dental sedation and general anesthesia among U.S. providers, according to a study in
Anesthesia Progress
.
August 17, 2010
Can cancer patients benefit from phase I drug trials?
By
Reuters Health
NEW YORK (Reuters Health), Aug 16 - Patients with advanced head and neck cancer survived just as well on experimental drugs in phase I trials as they did on FDA-approved standard therapies, a new report says.
August 15, 2010
Analgesics not the only choice for orthodontic pain
By
DrBicuspid.com staff writers
While some newer pain-management techniques have been shown to be effective, analgesics remain the primary treatment choice for controlling orthodontic pain, according to a new study.
August 12, 2010
Pa. college offers anesthesia course for hygienists
By
DrBicuspid.com staff writers
Montgomery County Community College is now offering a 30-hour accredited anesthesia course for licensed dental hygienists.
August 12, 2010
Milestone Scientific sees record profits in Q2
By
DrBicuspid.com staff writers
Milestone Scientific, maker of a computerized anesthesia injection system, announced record profits for the second quarter of 2010.
August 10, 2010
Milestone Scientific launches new corporate website
By
DrBicuspid.com staff writers
Milestone Scientific has developed a new corporate website designed to clarify and better convey Milestone's key messaging and current business information.
August 9, 2010
U.S. Senate committee passes pay-for-delay limit
By
DrBicuspid.com staff writers
A U.S. Senate committee on July 29 approved a provision meant to inhibit branded drug companies from delaying the introduction of generic versions of their drugs.
July 29, 2010
Aussie experts warn of conscious sedation risks
By
DrBicuspid.com staff writers
Conscious sedation is growing in popularity in Australia, but dental experts warn some dentists may be putting patients at risk by using the technique without proper training.
July 28, 2010
FTC campaigns against 'pay-for-delay'
By
DrBicuspid.com staff writers
The U.S. Federal Trade Commission (FTC) is trying to stop drug companies from paying each other not to introduce competing products, according to commission Chairman Jon Leibowitz.
July 28, 2010
Agencies plan painkiller restrictions
By
DrBicuspid.com staff writers
Washington state is preparing regulations intended to curb the overuse of prescription painkillers, according to an article in the
New York Times
.
July 28, 2010
Sanofi-Aventis, Novalar eye European market for OraVerse
By
DrBicuspid.com staff writers
Sanofi-Aventis and Novalar Pharmaceuticals announced that the Marketing Authorization Application for OraVerse has been accepted for review by the regulatory agencies of the U.K., Germany, Italy, France, and Spain.
July 22, 2010
Previous Page
Page 30 of 43
Next Page